首页> 外文OA文献 >ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens II: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

【2h】

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens II: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

机译：escmid研究组的损害主持人（Esgich）关于靶向和生物疗法安全的共识文件：传染病透视（靶向淋巴或骨髓细胞表面抗原的药剂II：CD22，CD30，CD33，CD38，CD40，SLamf -7和CCR4）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
L. Drgona; C. Gudiol; S. Lanini; B. Salzberger; G. Ippolito; M. Mikulska;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Re: 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies' by Mikulska et al. [J] . Wijetilleka S., Jayne D., Mukhtyar C., Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2019,第4期

机译：Re：'Escmid研究组的受损主机（Esgich）的感染（Esgich）共识文件，就Mikulska等人有针对性和生物疗法的安全。
2. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Immune checkpoint inhibitors cell adhesion inhibitors sphingosine-1-phosphate receptor modulators and proteasome inhibitors) [O] . Gil Redelman-Sidi, Olivier Michielin, Carlos Cervera, -1

机译：ESCMID弱势宿主感染研究组（ESGICH）关于靶向治疗和生物治疗安全性的共识文件：传染病的观点（免疫检查点抑制剂细胞粘附抑制剂鞘氨醇-1-磷酸受体调节剂和蛋白酶体抑制剂）
3. Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective [O] . J.M. Aguado, O. Manuel 2018

机译：埃斯科姆德研究组的社论为受损主持人（Esgich）的感染，关于有针对性和生物疗法的安全性的达成共识文件：传染病的观点

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens II: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

著录项

引文网络

相似文献

相关主题

期刊订阅